CONCLUSIONS	In this randomized controlled trial , simplification of therapy to fixed-dose TZV among patients with suppressed HIV RNA was perceived to be more convenient , and resulted in improved adherence and better role functioning , than continuing treatment with CBV/LPV/r .\